Novavax Announces Pricing of $65 Million Public Offering of Common Stock

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an underwritten public offering to sell 6,500,000 shares of its common stock at a public offering price of $10.00 per share, or $65 million worth of shares of its common stock. In connection with the common stock offering, Novavax…

thaipr.net

16 ธ.ค. 65

Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an offering of $150 million aggregate principal amount of its 5.00% convertible senior notes due 2027 (the “notes”). The notes are being offered and sold only to persons reasonably believed to be qualified […]

thaipr.net

16 ธ.ค. 65
1 1,815 1,816 1,817 1,818 1,819 3,348